Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 340, Pages 340ra73-340ra73
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-05-26
DOI
10.1126/scitranslmed.aad4059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia
- (2014) Ted Wun et al. PLoS One
- Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy
- (2013) B. Boyerinas et al. BLOOD
- Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial
- (2013) Hatem A. Azim et al. BREAST
- Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer
- (2013) Jeffrey B. Smerage et al. Molecular Oncology
- Distinct glycosyltransferases synthesize E-selectin ligands in human vs. mouse leukocytes
- (2013) Nandini Mondal et al. Cell Adhesion & Migration
- E-Selectin Ligands as Mechanosensitive Receptors on Neutrophils in Health and Disease
- (2012) S. D. Chase et al. ANNALS OF BIOMEDICAL ENGINEERING
- Selectin-deficiency reduces the number of spontaneous metastases in a xenograft model of human breast cancer
- (2012) Katrin Stübke et al. CANCER LETTERS
- Circulating tumour cells in non-metastatic breast cancer: a prospective study
- (2012) Anthony Lucci et al. LANCET ONCOLOGY
- Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells
- (2012) Venktesh S. Shirure et al. PLoS One
- Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy
- (2012) MARÍA JOSÉ SERRANO et al. Experimental and Therapeutic Medicine
- Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade
- (2012) Yue Geng et al. Frontiers in Oncology
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Direct Measurements on CD24-Mediated Rolling of Human Breast Cancer MCF-7 Cells on E-Selectin
- (2011) Ja Hye Myung et al. ANALYTICAL CHEMISTRY
- Gangliosides expressed on breast cancer cells are E-selectin ligands
- (2011) Venktesh S. Shirure et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow
- (2011) A. Zarbock et al. BLOOD
- Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells
- (2011) J. S. Merzaban et al. BLOOD
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT)
- (2010) F. T. Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
- (2009) M Murohashi et al. BRITISH JOURNAL OF CANCER
- From carbohydrate leads to glycomimetic drugs
- (2009) Beat Ernst et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started